meta[bolic] And ŌURA Partner To Manage Metabolic Disease

For millions of people around the world, managing a metabolic disease can be emotionally challenging and complex. Metabolic issues are difficult to treat because they often require foundational behavioral changes combined with clinical interventions based on accurate medical data.

meta[bolic], a Dubai-based hybrid therapeutics company dedicated to managing chronic metabolic disease, aims to help people to better manage their metabolic health by partnering with ŌURA, the startup behind the Oura Ring — a smart wearable that delivers health data, and daily guidance into sleep, activity, readiness, and recovery.

“Wearables have come a long way in just the past few years,” explained Ali Hashemi, co-founder and chief executive officer of meta[bolic]. “Oura Ring is a step above the wearables of yesterday in terms of data fidelity and quality, but also in terms of interface and useful insights delivered to users. We are eager to bring ŌURA’s continuous monitoring and daily engagement to our patients, unlocking new capabilities around preventive care, behavior change, and habits”.

The partnership between ŌURA and meta[bolic] aims to empower patients with robust support and continuous remote data monitoring. By consistently tracking patient progress and identifying behavior patterns, the initiative will become a first step in a more integrated approach to preventive care.

“At ŌURA, we envision a future where the model for preventative care is multi-faceted and unique to each individual,” added Tom Hale, Chief Executive Officer of ŌURA. “True innovation in healthcare is driven by providers who are implementing multidimensional care and using integrated technology to empower people to make changes to their daily behavior that improve health and well-being”.

Also Read: Mobile Trends Shaping MENA In 2024

The  ŌURA and meta[bolic] partnership will also include a dedicated research program to explore the relationship between sleep, stress, and metabolic health. The resulting data will provide useful biomarkers to measure how engagement levels and sleep impact glucose improvement.

The results of the research are expected within 12 months and will act as a framework for approaching metabolic health in a more comprehensive way while generating valuable insights for the scientific community and members of the public.